3 Results for "

CD28-B7 interactions

" in MedChemExpress (MCE) Product Catalog:
Products (3)

3 Results for "CD28-B7 interactions" in MCE Product Catalog:

Cat. No.: HY-175780
CAS No.: 1465291-19-3
Research Areas:  

Cancer

CD28-IN-1 (Compound 19MS-5) is a CD28 inhibitor with a KD of 12.48  μM. CD28-IN-1 has a superior binding capacity to CD28 and potently inhibits CD28-B7 interactions. CD28-IN-1 inhibits CD28-driven immune activation and suppresses cytokine (IFN-γ, IL-2 and TNF-α) production in primary human T cells co-cultured with tumor spheroids and human epithelial tissues. CD28-IN-1 can be used for tumor immunity research .
loading...
    loading...
Cat. No.: HY-179648
CAS No.: 1240857-57-1
Target:  

CD28

Research Areas:  

Inflammation/Immunology Cancer

CD28-IN-2 is a selective CD28-B7 interaction (IC50: 22.4 μM) inhibitor that binds directly to CD28, with a Kd value of 24.1 μM. CD28-IN-2 inhibits CD28-driven immune activation and blocks T cell costimulation. CD28-IN-2 can be used for the study of antitumor immunity and immune-related disorders .
loading...
    loading...
Cat. No.: HY-181507
CAS No.: 850550-70-8
Research Areas:  

Cancer

CD28-IN-3 is a CD28 inhibitor with an IC50 of 7.80 μM and a Kd of 52.45 μM. CD28-IN-3 selectively blocks the CD28-B7 interaction, thereby inhibiting CD28-mediated costimulation. CD28-IN-3 suppresses the production of proinflammatory cytokines IFN-γ, IL-2 and TNF-α. CD28-IN-3 can be used in the research of checkpoint-resistant cancers .
loading...
    loading...